U.S. Markets closed
  • S&P Futures

    3,656.50
    +33.25 (+0.92%)
     
  • Dow Futures

    29,888.00
    +259.00 (+0.87%)
     
  • Nasdaq Futures

    12,389.50
    +112.50 (+0.92%)
     
  • Russell 2000 Futures

    1,843.00
    +22.90 (+1.26%)
     
  • Crude Oil

    44.97
    -0.37 (-0.82%)
     
  • Gold

    1,789.00
    +8.10 (+0.45%)
     
  • Silver

    22.98
    +0.39 (+1.71%)
     
  • EUR/USD

    1.1963
    +0.0029 (+0.2393%)
     
  • 10-Yr Bond

    0.8440
    +0.0020 (+0.24%)
     
  • Vix

    20.57
    -0.27 (-1.30%)
     
  • GBP/USD

    1.3358
    +0.0027 (+0.2004%)
     
  • USD/JPY

    104.4370
    +0.1130 (+0.1083%)
     
  • BTC-USD

    19,550.01
    +40.13 (+0.21%)
     
  • CMC Crypto 200

    383.71
    +19.12 (+5.24%)
     
  • FTSE 100

    6,266.19
    -101.39 (-1.59%)
     
  • Nikkei 225

    26,824.46
    +390.84 (+1.48%)
     

Owens & Minor: Q3 Earnings Insights

Benzinga Insights
·1 min read

Shares of Owens & Minor (NYSE:OMI) fell 0.61% in after-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share increased 305.00% year over year to $0.81, which beat the estimate of $0.67.

Revenue of $2,188,000,000 decreased by 8.80% from the same period last year, which beat the estimate of $2,080,000,000.

Guidance

The upcoming fiscal year's EPS expected to be between $1.90 and $2.00.

Owens & Minor hasn't issued any revenue guidance for the time being.

Details Of The Call

Date: Nov 02, 2020

View more earnings on OMI

Time: 05:00 PM

ET Webcast URL: https://edge.media-server.com/mmc/p/muixea9t

Recent Stock Performance

Company's 52-week high was at $27.75

Company's 52-week low was at $3.63

Price action over last quarter: Up 81.75%

Company Profile

Owens & Minor distributes consumable medical supplies to a variety of providers. The company operates in two segments that are Global products and Global Solutions. The company offers a portfolio of products and services to healthcare providers and manufacturers in the Global solutions segment. In the Global product segment, the company manufactures and sources medical-surgical products through our production and kitting operations. The majority of the revenue is generated from the Global solutions segment. The company operates in Asia, Europe, Latin America, and the United States, while the majority of revenue comes from the United States.

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.